Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-23-003475

President and CEO sold 11,250 shares at $26.88 ($302,400)

  • President and CEO gave up 103,857 shares (to pay taxes)
  • President and CEO acquired 11,250 shares (option exercise)
  • President and CEO acquired 255,194 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ciaffoni Joseph · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-10 Grant or award : show line 1 in the form +117,500 366,250 D
2023-02-10 Grant or award : show line 2 in the form +137,694 503,944 D
2023-02-10 Shares withheld for taxes : show line 3 in the form −44,121 $26.75 $1,180,237 459,823 D
2023-02-10 Shares withheld for taxes : show line 4 in the form −59,736 $26.75 $1,597,938 400,087 D
2023-02-13 Exercise or conversion : show line 5 in the form +11,250 $15.90 $178,875 411,337 D
2023-02-13 Sale : show line 6 in the form −11,250 $26.88 $302,400 400,087 D
Open-market sales · 11,250 sh · avg $26.88 · $302,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Exercise or conversion : show line 7 in the form Stock Option (Right to Purchase) −11,250 0 D
Loading xslF345X03/form4.xml…